This website does readability filtering of other pages. All styles, scripts, forms and ads are stripped. If you want your website excluded or have other feedback, use this form.

16. Copper Complexes in Cancer Therapy : Metallo-Drugs: Development and Action of Anticancer Agents

Jump to ContentJump to Main NavigationLanguages Languages

User Account Search (0)

My CartAdded To Cart

Check Out Menu Show Summary Details More options … Download single chapters here!

Metallo-Drugs: Development and Action of Anticancer Agents

Ed. by Sigel, Astrid / Sigel, Helmut / Freisinger, Eva / Sigel, Roland K.O.

With contrib. by Riddell, Imogen / Lippard, Stephen J. / Brabec, Victor / Kasparkova, Jana / Menon, Vijay / Farrell, Nicholas P. / Venkatesh, V. / Sadler, Peter J. / Gorle, Anil K. / Peterson, Erica J. / Berners-Price, Susan / Alessio, Enzo / Messori, Luigi / Babak, Maria V. / Ang, Wee Han / Casini, Angela / Sun, Raymond Wai-Yin / Ott, Ingo / Tshuva, Edit / Miller, Maya / Crans, Debbie / Yan, Lining / Haase, Allison / Yang, Xiaogai / Chitambar, Christopher / Cardo, Lucia / Hannon, Michael John / Vilar, Ramon / Sullivan, Matthew P. / Holtkamp, Hannah U. / Hartinger, Christian G. / Schatzschneider, Ulrich / Thévenod, Frank / Denoyer, Delphine / Clatworthy, Sharnel A. S. / Cater, Michael / Ziliotto, Silvia / Ogle, Olivia / Taylor, Kathryn M.

Series:Metal Ions in Life Sciences 18

See all formats and pricing
eBook (PDF)
Publication Date:
February 2018
Copyright year:
2018
ISBN
978-3-11-047073-4
See all formats and pricing
eBook (PDF)ISBN 978-3-11-047073-4
RRP € [D] 220.00 / US$ 250.00 / GBP 200.00*
eBook (EPUB)ISBN 978-3-11-046990-5
RRP € [D] 220.00 / US$ 250.00 / GBP 200.00*
HardcoverISBN 978-3-11-046984-4
RRP € [D] 220.00 / US$ 250.00 / GBP 200.00*
*Prices in US$ apply to orders placed in the Americas only. Prices in GBP apply to orders placed in Great Britain only. Prices in € represent the retail prices valid in Germany (unless otherwise indicated). Prices are subject to change without notice. Prices do not include postage and handling if applicable. Free shipping for non-business customers when ordering books at De Gruyter Online. Please find details to our shipping fees here. RRP: Recommended Retail Price. Previous chapter Next chapter

16. Copper Complexes in Cancer Therapy

Denoyer, Delphine / Clatworthy, Sharnel A. S. / Cater, Michael A.

30,00 € / $42.00 / £23.00

Get Access to Full Text

Abstract

Copper homeostasis is tightly regulated in both prokaryotic and eukaryotic cells to ensure sufficient amounts for cuproprotein biosynthesis, while limiting oxidative stress production and toxicity. Over the last century, copper complexes have been developed as antimicrobials and for treating diseases involving copper dyshomeostasis (e.g., Wilson’s disease). There now exists a repertoire of copper complexes that can regulate bodily copper through a myriad of mechanisms. Furthermore, many copper complexes are now being appraised for a variety of therapeutic indications (e.g., Alzheimer’s disease and amyotrophic lateral sclerosis) that require a range of copper-related pharmacological affects. Cancer therapy is also drawing considerable attention since copper has been recognized as a limiting factor for multiple aspects of cancer progression including growth, angiogenesis, and metastasis. Consequently, ‘old copper complexes’ (e.g., tetrathiomolybdate and clioquinol) have been repurposed for cancer therapy and have demonstrated anticancer activity in vitro and in preclinical models. Likewise, new tailor-made copper complexes have been designed based on structural and biological features ideal for their anticancer activity. Human clinical trials continue to evaluate the therapeutic efficacy of copper complexes as anticancer agents and considerable progress has been made in understanding their pharmacological requirements. In this chapter, we present a historical perspective on the main copper complexes that are currently being repurposed for cancer therapy and detail several of the more recently developed compounds that have emerged as promising anticancer agents. We further provide an overview of the known mechanisms of action, including molecular targets and we discuss associated clinical trials.

Citation Information

Delphine Denoyer, Sharnel A. S. Clatworthy, Michael A. Cater (2018). 16. Copper Complexes in Cancer Therapy. In Astrid Sigel, Helmut Sigel, Eva Freisinger, Roland K.O. Sigel (Eds.), Metallo-Drugs: Development and Action of Anticancer Agents (pp. 469–506). Berlin, Boston: De Gruyter. [doi.org]

Book DOI: [doi.org]

Online ISBN: 9783110470734

© 2018 Walter de Gruyter GmbH, Berlin/Munich/Boston

Comments (0)

Please log in or register to comment. Log inRegister General note: By using the comment function on degruyter.com you agree to our Privacy Statement. A respectful treatment of one another is important to us. Therefore we would like to draw your attention to our House Rules. Copyright © 2011–2019 by Walter de Gruyter GmbH Powered by PubFactory
  • [199.195.251.176]
  • 199.195.251.176